|
|
|
|
|
Last Trade
|
Last Trade:
$0.25
|
Change:
0.00 (0.00%)
|
Trade Time:
Apr 29
|
Market Cap:
$0.27M
|
|
|
|
|
Description of Business
|
|
American Biogenetic Sciences, Inc. ("ABS" or the "Company") is a
development stage company engaged in researching, developing and marketing
cardiovascular and neurobiology products for commercial development and
distributing vaccines. The Company commenced selling its products during the
last quarter of 1997, although it has not yet derived any significant revenues
from the sale of these products.
The Company's products are designed for in vitro and in vivo diagnostic
procedures and therapeutic drugs. In vitro diagnostic procedures are those in
which blood, urine or other bodily fluid or tissue is extracted from the body
and diagnostic tests are performed in a test tube or other laboratory equipment.
In vivo diagnostic procedures are those in which proteins or compounds are
injected directly into the body or bloodstream to assess abnormal reactions or
conditions.
|
|
|
|